Pulmonary Function, Muscle Strength, Time to Extubation and Quality of Recovery in the Post Anesthesia Care Unit After Reversal of Neuromuscular Blockade With Neostigmine or Sugammadex.

Trial Profile

Pulmonary Function, Muscle Strength, Time to Extubation and Quality of Recovery in the Post Anesthesia Care Unit After Reversal of Neuromuscular Blockade With Neostigmine or Sugammadex.

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 13 Nov 2017

At a glance

  • Drugs Sugammadex (Primary) ; Neostigmine
  • Indications Neuromuscular blockade
  • Focus Therapeutic Use
  • Most Recent Events

    • 06 Nov 2017 Planned End Date changed from 1 Sep 2017 to 1 Dec 2017.
    • 06 Nov 2017 Planned primary completion date changed from 1 Sep 2017 to 1 Nov 2017.
    • 31 May 2017 Planned number of patients changed from 60 to 80.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top